共 47 条
[1]
Klatte T(2007)Prognostic factors for renal cell carcinoma with tumor thrombus extension J Urol 178 1189-1195
[2]
Pantuck AJ(2022)Jikei-Kyoto-Osaka-Nagasaki-Ganken Group (J-KONG Group): Intra- and post-operative management of pancreatic injury during laparoscopic nephrectomy Int J Urol 29 905-907
[3]
Riggs SB(2022)Lenvatinib plus pembrolizumab combination therapy for adult patients with advanced renal cell carcinoma Expert Rev Anticancer Ther 22 1049-1059
[4]
Miki J(2022)Immune checkpoint inhibitor combination therapy for renal cell carcinomas with concomitant inferior vena cava thrombi In Vivo 9 101800-129
[5]
Yamasaki T(2021)Pathological complete response of renal cell carcinoma with vena cava tumor thrombus to neoadjuvant TKI/IO combination therapy Urol Case Rep 3 124-248
[6]
Komai Y(2023)Pathological complete response to preoperative nivolumab plus cabozantinib for renal cell carcinoma with inferior vena cava thrombus: a case report Cancer Diagn Progn 22 244-1769
[7]
Ged Y(2020)Management of pancreatic injuries following nephrectomy Isr Med Assoc J 47 1763-385
[8]
Lee CH(2015)Possible impact of continuous drainage after minimally invasive partial nephrectomy Int Urol Nephrol 31 379-S20
[9]
Yoshida K(2013)Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC) Urol Oncol 6 S8-1833
[10]
Hata K(2017)Evaluation of rare but severe immune related adverse effects in PD-1 inhibitors in non-small cell lung cancer: a meta-analysis Transl Lung Cancer Res 375 1823-1550